2021 update of the International Council for Standardization in Haematology recommendations for laboratory measurement of direct oral anticoagulants
J Douxfils, DM Adcock, SM Bates… - Thrombosis and …, 2021 - thieme-connect.com
In 2018, the International Council for Standardization in Haematology (ICSH) published a
consensus document providing guidance for laboratories on measuring direct oral …
consensus document providing guidance for laboratories on measuring direct oral …
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients
Cochrane, Maria Crespo Leiro, Anne Dipchand, Brian Feingold, Kathleen Grady, Edward
Horn, Maryl Johnson, Donna Mancini, Sean Pinney, Heather Ross, Kari Wujcik, Andreas …
Horn, Maryl Johnson, Donna Mancini, Sean Pinney, Heather Ross, Kari Wujcik, Andreas …
International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants
RC Gosselin, DM Adcock, SM Bates… - Thrombosis and …, 2018 - thieme-connect.com
This guidance document was prepared on behalf of the International Council for
Standardization in Haematology (ICSH) for providing haemostasis-related guidance …
Standardization in Haematology (ICSH) for providing haemostasis-related guidance …
Efficacy and safety of non-vitamin K antagonist oral anticoagulants in pediatric venous thromboembolism treatment and thromboprophylaxis: a systematic review of the …
JW Branstetter, AL Kiskaddon, MA King… - … in Thrombosis and …, 2021 - thieme-connect.com
Venous thromboembolism (VTE) in children can lead to significant morbidity and mortality.
Traditionally, treatment for thrombotic events in pediatric patients has been limited mainly to …
Traditionally, treatment for thrombotic events in pediatric patients has been limited mainly to …
Computational modeling of blood component transport related to coronary artery thrombosis in Kawasaki disease
N Grande Gutiérrez, M Alber, AM Kahn… - PLoS computational …, 2021 - journals.plos.org
Coronary artery thrombosis is the major risk associated with Kawasaki disease (KD). Long-
term management of KD patients with persistent aneurysms requires a thrombotic risk …
term management of KD patients with persistent aneurysms requires a thrombotic risk …
Apixaban for prevention of thromboembolism in pediatric heart disease
RM Payne, KM Burns, AC Glatz, C Male, A Donti… - Journal of the American …, 2023 - jacc.org
Background Children with heart disease frequently require anticoagulation for
thromboprophylaxis. Current standard of care (SOC), vitamin K antagonists or low-molecular …
thromboprophylaxis. Current standard of care (SOC), vitamin K antagonists or low-molecular …
[HTML][HTML] Real-world use of apixaban for the treatment and prevention of thrombosis in children with cardiac disease
C VanderPluym, P Esteso, A Ankola, A Hellinger… - Journal of Thrombosis …, 2023 - Elsevier
Background Direct oral anticoagulants use in pediatric cardiology is poorly defined.
Objective We present the largest experience of apixaban use in children with heart disease …
Objective We present the largest experience of apixaban use in children with heart disease …
50 years of pediatric hemostasis: knowledge, diagnosis, and treatment
S Levy-Mendelovich, O Cohen… - … in Thrombosis and …, 2023 - thieme-connect.com
Studies from the past 50 years have contributed to the expanding knowledge regarding
developmental hemostasis. This is a dynamic process that begins in the fetal phase and is …
developmental hemostasis. This is a dynamic process that begins in the fetal phase and is …
Direct oral anticoagulants for use in paediatrics
J Jaffray, G Young - The Lancet Child & Adolescent Health, 2022 - thelancet.com
With the increasing incidence of thromboembolism in children and improvement in
management for patients with medically complex diseases, expanded availability of safe …
management for patients with medically complex diseases, expanded availability of safe …
Evaluation, analysis, and reporting of medication adherence for clinical trials of anticoagulants in children: guidance from the ISTH SSC Subcommittee on Pediatric …
ME McGrady, V Ignjatovic, S Jones, A Bruce… - Journal of Thrombosis …, 2024 - Elsevier
In response to growing recognition that nonadherence prevents children, adolescents, and
young adults from achieving the therapeutic benefits of anticoagulant medication, the …
young adults from achieving the therapeutic benefits of anticoagulant medication, the …